​

Teva Pharmaceutical Industries Ownership | Who Owns Teva Pharmaceutical Industries?

OverviewForecastRevenueFinancialsChartTranscripts

Teva Pharmaceutical Industries Ownership Summary

Teva Pharmaceutical Industries is owned by 33.70% institutional investors, 0.16% insiders, and 66.14% retail investors. Fmr is the largest institutional shareholder, holding 7.24% of TEVA shares. Fidelity Contrafund is the top mutual fund, with 1.64% of its assets in Teva Pharmaceutical Industries shares.

TEVA Ownership Benchmark

TypeName% Inst% Insiders% Retail
StockTeva Pharmaceutical Industries33.70%0.16%66.14%
SectorHealthcare Stocks 57.39%9.93%32.68%
IndustrySpecialty & Generic Drug Manufacturers Stocks26.69%10.91%62.39%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Fmr81.98M7.24%$1.81B
Blackrock funding, inc. /de50.58M4.46%$1.11B
Blackrock42.99M3.83%$698.55M
Clal insurance enterprises38.96M3.44%$859.93M
Ion asset management36.65M3.23%$807.77M
Migdal insurance & financial29.12M2.59%$473.17M
Menora mivtachim28.38M2.50%$625.52M
Exor capital llp27.19M2.40%$599.32M
Phoenix21.21M1.87%$467.52M
State street17.72M1.58%$287.99M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ion asset management36.65M47.03%$807.77M
Exor capital llp27.19M16.08%$599.32M
Noked israel3.29M14.25%$72.41M
Tri locum partners lp2.42M11.06%$53.41M
Spartan fund management148.30K10.91%$3.27M
Bridger management695.00K8.23%$15.32M
Migdal insurance & financial29.12M7.90%$473.17M
Parsifal capital management, lp6.70M7.85%$108.83M
Clal insurance enterprises38.96M7.75%$859.93M
Phoenix21.21M6.38%$467.52M

Top Buyers

HolderShares% AssetsChange
Fmr81.98M0.11%19.24M
Morgan stanley13.14M0.02%7.71M
Duquesne family office9.00M5.33%7.57M
Blackrock funding, inc. /de50.58M0.02%6.78M
Clal insurance enterprises38.96M7.75%4.42M

Top Sellers

HolderShares% AssetsChange
Arrowstreet capital, limited partnership6.99M0.12%-7.91M
Millennium management6.54M0.07%-5.27M
Slate path capital lp8.49M3.38%-5.18M
Neuberger berman group29.40K0.00%-3.88M
Deutsche bank ag\2.21M0.02%-2.71M

New Positions

HolderShares% AssetsChangeValue
Todd asset management2.64M1.40%2.64M$58.24M
Raymond james financial1.77M0.01%1.77M$38.91M
Norges bank1.75M0.01%1.75M$38.55M
Teachers retirement system of the state of kentucky1.71M0.33%1.71M$37.69M
Driehaus capital management1.42M0.22%1.42M$23.12M

Sold Out

HolderChange
West branch capital-1.00
Nbt bank n a /ny-4.00
Register financial advisors-29.00
Foster dykema cabot & partners-33.00
St germain d j-37.00

Institutional Ownership Trends

DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 2024373-35.69%381,844,579-39.91%331.07%172-35.34%114-33.33%
Sep 30, 20245762.13%635,409,4364.34%561.94%264-1.49%1706.25%
Jun 30, 20245579.22%608,962,9466.60%542.10%2631.94%15925.20%
Mar 31, 20245106.47%571,233,553-1.26%501.91%25831.63%127-11.19%
Dec 31, 20234792.79%578,520,1014.69%512.12%1965.38%14311.72%

Top Mutual Funds Shareholders

HolderShares% HoldingChange
Fidelity Contrafund18.74M1.64%-
Fidelity Contrafund Commingled Pl S7.39M0.64%-305.44K
iShares Core MSCI EAFE ETF7.16M0.62%-
AustralianSuper Balanced Sup5.60M0.49%-504.89K
Fidelity Contrafund Commingled Pl O5.16M0.46%244.15K
EAFE Equity Index Fund T5.07M0.44%-43.51K
Fidelity Global Innovators Cl F4.93M0.43%650.27K
EAFE Equity Index Fund F4.77M0.42%161.86K
Fidelity Blue Chip Growth4.67M0.41%-
Fidelity Contrafund K64.30M0.38%-12.87K

Recent Insider Transactions

DateNameRoleActivityValue
Mar 05, 2025Daniell Richard Exec. VP, European CommercialSell$359.27K
Mar 05, 2025Daniell Richard Exec. VP, European CommercialSell$769.37K
Mar 04, 2025Hughes Eric A See "Remarks"Sell$238.76K
Mar 05, 2025Hughes Eric A See "Remarks"Sell$128.53K
Mar 05, 2025Daniell Richard Exec. VP, European CommercialSell$477.63K

Insider Transactions Trends

DateBuySell
2025 Q1-20
2024 Q4-2
2024 Q3-4
2024 Q2-4
2024 Q1-16

TEVA Ownership FAQ

Who Owns Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries shareholders are primarily institutional investors at 33.70%, followed by 0.16% insiders and 66.14% retail investors. The average institutional ownership in Teva Pharmaceutical Industries's industry, Specialty & Generic Drug Manufacturers Stocks, is 26.69%, which Teva Pharmaceutical Industries exceeds.

Who owns the most shares of Teva Pharmaceutical Industries?

Teva Pharmaceutical Industries’s largest shareholders are Fmr (81.98M shares, 7.24%), Blackrock funding, inc. /de (50.58M shares, 4.46%), and Blackrock (42.99M shares, 3.83%). Together, they hold 15.53% of Teva Pharmaceutical Industries’s total shares outstanding.

Does Blackrock own Teva Pharmaceutical Industries?

Yes, BlackRock owns 3.83% of Teva Pharmaceutical Industries, totaling 42.99M shares as of Jun 2024. This represents 0.02% of BlackRock's total assets, with a market value of 698.55M$. In the last quarter, BlackRock decreased its holdings by -717K shares, a -1.64% change.

Who is Teva Pharmaceutical Industries’s biggest shareholder by percentage of total assets invested?

Ion asset management is Teva Pharmaceutical Industries’s biggest shareholder by percentage of total assets invested, with 47.03% of its assets in 36.65M Teva Pharmaceutical Industries shares, valued at 807.77M$.

Who is the top mutual fund holder of Teva Pharmaceutical Industries shares?

Fidelity Contrafund is the top mutual fund holder of Teva Pharmaceutical Industries shares, with 1.64% of its total shares outstanding invested in 18.74M Teva Pharmaceutical Industries shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools